Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today -- / --
Volume --
MOR On Other Exchanges
MOR is not on other exchanges.
As of -- All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel Camus

Member of Supervisory Board and Chairman of Audit Committee, Morphosys AG
AgeTotal Calculated CompensationThis person is connected to 79 board members in 8 different organizations across 13 different industries.

See Board Relationships


Dr. Daniel Camus has been a Senior Advisor of Roland Berger Strategy Consultants since June 2011. Dr. Camus served as a Group Senior Executive Vice President of Electricite de France SA from November 2004 to November 18, 2010. He served as a Finance Director of EDF Energy Plc. He served as a General Manager of EDF SA. He served as the Chief Financial Officer at Electricite de France SA from November 2004 to March 29, 2010 and also served as Member of its Management Board. ...

Read Full Background

Corporate Headquarters*

Lena-Christ-Strasse 48
Martinsried, Bavaria 82152


Phone: 49 8989 9270
Fax: 49 89 8992 7222

Board Members Memberships*

Former Vice Chairman and Member of Executive committee
Former Director and Chairman of the Audit Committee
Independent Director and Chairman of Audit & Risks Committee
Former Director, Member of Executive Committee and Member of Committee on Nuclear Power
Independent Director, Member of Safety, Health & Environment Committee, Member of Audit & Finance Committee and Member of Human Resources & Compensation Committee


Institut d'Etudes Politiques de Paris
Université de la Sorbonne - Université de Paris

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€69,360
Total Calculated Compensation€69,360
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOR:GR €57.00 EUR -0.94


Daniel M. Junius Chief Executive Officer, President and Director
ImmunoGen, Inc.
John W. Varian Chief Executive Officer, President and Director
XOMA Corporation
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
Edwin Moses Ph.D.Chief Executive Officer and Director
Ablynx NV
Randal J. Kirk J.D.Chairman, Chief Executive Officer and President
Intrexon Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MORPHOSYS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at